Research & University News

EMA reaches out to academia

The European Medicines Agency EMA) has formalised its ongoing relationship with universities in order to tap into research that could lead to new medicines and provide regulatory guidance to academic entrepreneurs.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

Parkinson’s disease linked to gut bacteria

While most efforts at treating Parkinson’s disease have involved brain research, scientists from the California Institute of Technology (Caltech) have now shown in experiments with mice that bacteria in the gut may be releasing chemicals that over-activate parts of the brain leading to the disease.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States

Genome sequenced using hand-held device

UK researchers have reported sequencing the whole genomes of a human donor and a patient using a hand-held device based on nanopore technology. The device was developed by Oxford Nanopore Technologies Ltd, a venture capital-backed company based in Oxford UK.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

Safety mechanism for autoimmunity

Researchers at the Karolinska Institutet have identified a previously unknown safety mechanism in the immune system that protects the body from autoimmune diseases. The discovery may be the key to countering autoimmune diseases, such as systemic lupus erythematosus (SLE), they contend.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Sweden

Gut linked to drug response

Immunotherapy for treating metastasised melanoma works better when there is a diversity of bacteria in the gut, according to a study by researchers at the University of Texas MD Anderson Cancer Center in the US.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

Transcription factor guides mitosis

As embryonic stem cells divide, they are able to express the same genes as the original cell despite all the possibilities of mutation. Now, scientists from the Institut Pasteur have identified a transcription factor, Esrrb (estrogen related receptor beta), that makes this possible.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

France

Damaged neurons repaired

German scientists have successfully replaced damaged nerve cells in the brains of mice fueling hope that the wreckage caused by Alzheimer’s or Parkinson’s disease might be repaired in the future. Normally, nerve cell losses in the brain cannot be restored.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany

Cell Medica goes allogeneic

Cell Medica Ltd has expanded an existing partnership with the Baylor College of Medicine in Texas, US to develop allogeneic cell therapies based on engineered immune cells generated from healthy donors. The cells are invariant natural killer T (NKT) cells.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

Syncona merger targets UK science

Syncona LLP, the evergreen investment fund of the Wellcome Trust, is poised to increase its investment in UK life science through a merger with the Guernsey-based investment fund BACIT Ltd. The new group will keep the Syncona name and be listed on the London Stock Exchange.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

Explaining cancer risk

Research carried out in the Netherlands shows that a person’s risk of getting cancer cannot be explained by the number of errors found in DNA. Scientists at the University Medical Center Utrecht and the Hubrecht Institute have come to this conclusion after mapping the genetic profile of organoids.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Netherlands

Syndicate content